Abdallah F, Mijouin L, Pichon C. Skin immune landscape: inside and outside the organism.
Mediators of Inflammation 2017: ID 5095293. 2017.
Bellei B, Pitisci A, Catricalà C, Larue L, Picardo M. Wnt/β-catenin signaling is stimulated by α-melanocyte-stimulating hormone in melanoma and melanocyte cells: implication in cell differentiation.
Pigment Cell & Melanoma Research 24: 309-325. 2011.
Groeber F, Holeiter M, Hampel M, Hinderer S, Schenke-Layland K. Skin tissue engineering: in vivo and
in vitro applications.
Advanced Drug Delivery Reviews 63: 352-366. 2011.
Hino S, Tanji C, Nakayama KI, Kikuchi A. Phosphorylation of β-catenin by cyclic AMP-dependent protein kinase stabilizes β-catenin through inhibition of its ubiquitination.
Molecular and Cellular Biology 25: 9063-9072. 2005.
Jannasch M, Groeber F, Brattig NW, Unger C, Walles H, Hansmann J. Development and application of three-dimensional skin equivalents for the investigation of percutaneous worm invasion.
Experimental Parasitology 150: 22-30. 2015.
Kerdudo A, Burger P, Merck F, Dingas A, Rolland Y, Michel T, Fernandez X. Development of a natural ingredient-natural preservative: a case study.
Comptes Rendus Chimie 19: 1077-1089. 2016.
Kim BH. The introduction of alternative method of reconstructed human skin equivalents for the assessment of skin irritation. Asian Journal of Beauty and Cosmetology 9: 139-147. 2011.
Koster MI. Making an epidermis.
Annals of the New York Academy of Sciences 1170: 7-10. 2009.
Lee JH. Wnt signaling in hair follicle development.
Asian Journal of Beauty and Cosmetology 15: 242-246. 2017.
Li Y, Shao Y, Tong Y, Shen T, Zhang J, Li Y, Gu H, Li F. Nucleocytoplasmic shuttling of PAK4 modulates β-catenin intracellular translocation and signaling.
Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1823: 465-475. 2012.
Lin JY, Fisher DE. Melanocyte biology and skin pigmentation.
Nature 445: 843-850. 2007.
Murray BW, Guo C, Piraino J, Westwick JK, Zhang C, Lamerdin J, Dagostino E, Knighton D, Loi CM, Zager M, et al. Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growth.
Proceedings of the National Academy of Sciences of the United States of America 107: 9446-9451. 2011.
Ponec M. Skin constructs for replacement of skin tissues for
in vitro testing.
Advanced Drug Delivery Reviews 54: S19-S30. 2002.
Schepsky A, Bruser K, Gunnarsson GJ, Goodall J, Hallsson JH, Goding CR, Steingrimsson E, Hecht A. The microphthalmia-associated transcription factor Mitf interacts with β-catenin to determine target gene expression.
Molecular and Cellular Biology 26: 8914-8927. 2006.
Vinardell MP. The use of non-animal alternatives in the safety evaluations of cosmetics ingredients by the Scientific Committee on Consumer Safety (SCCS).
Regulatory Toxicology and Pharmacology 71: 198-204. 2015.
Vinardell MP, Mitjans M. Alternative methods to animal testing for the safety evaluation of cosmetic ingredients: an overview.
Cosmetics 4: 30. 2017.
Wickett RR, Visscher MO. Structure and function of the epidermal barrier.
American Journal of Infection Control 34: S98-S110. 2006.
Yun CY, You ST, Kim JH, Chung JH, Han SB, Shin EY, Kim EG. p21-activated kinase 4 critically regulates melanogenesis via activation of the CREB/MITF and β-catenin/MITF pathways.
The Journal of Investigative Dermatology 135: 1385-1394. 2015.